National database for bronchoscopic treatment of emphysema in the Netherlands
Bronchoscopic Lung Volume Reduction Treatment in Clinical Practice: Introduction and Implementation in The Netherlands and Evaluation of a National Database
This study is creating a national database to track how well new bronchoscopic treatments work for people with severe emphysema in the Netherlands over five years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | University Medical Center Groningen Academic / other |
| Locations | 2 sites (Groningen and 1 other locations) |
| Trial ID | NCT02815683 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop a national database to record bronchoscopic lung volume reduction procedures for patients with severe emphysema in the Netherlands. By collecting real-world data on the effectiveness of these new treatments, the study seeks to ensure that the benefits observed in clinical trials are reflected in clinical practice. The study will follow patients for five years, assessing key parameters such as Target Lung Volume Reduction and valve placement accuracy through CT scans. This initiative will facilitate research and improve the use of novel therapies for emphysema.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with severe emphysema scheduled for bronchoscopic lung volume reduction treatment using one-way valves.
Not a fit: Patients who are not scheduled for bronchoscopic lung volume reduction treatment or have mild emphysema may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and effectiveness of bronchoscopic treatments for emphysema, leading to improved patient outcomes.
How similar studies have performed: Other studies have shown promise with similar bronchoscopic approaches for emphysema, indicating potential for success in this observational study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient is scheduled for a bronchoscopic lung volume treatment using one-way valves. Exclusion Criteria: * There are no exclusion criteria for this study.
Where this trial is running
Groningen and 1 other locations
- University Medical Center Groningen — Groningen, Netherlands (Recruiting)
- Maastricht University Medical Center — Maastricht, Netherlands (Recruiting)
Study contacts
- Principal investigator: Dirk-Jan Slebos, MD PhD — University Medical Center Groningen
- Study coordinator: Karin Klooster, PhD
- Email: k.klooster@umcg.nl
- Phone: +31503616161
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.